Market highlights for next week: Verizon, Boeing and Google reporting

Monday, January 28

Verizon Communications (NYSE: VZ) is reporting Q4 earnings; conference call at 8:30am.
Halliburton Company (NYSE: HAL) is reporting Q4 earnings; conference call at 9am.
Compass Diversified Holdings (NASDAQ: CODI) to hold conference call to discuss the acquisition of Staffmark Investment & Fox Factory.
Warner Chilcott Ltd. (NASDAQ: WCRX) to hold conference call to give 2008 guidance.

Tuesday, January 29

PDUFA date for GlaxoSmithKline plc (ADR) (NYSE: GSK)'s Cervarix, a cervical cancer vaccine.
JetBlue Airways Corporation (NASDAQ: JBLU) to report Q4 earnings; conference call at 10:00am.
United States Steel Corporation (NYSE: X) to report Q4 earnings; conference call at 3:00pm.
Yahoo! Inc. (NASDAQ: YHOO) to report Q4 earnings; conference call at 5:00pm.

Wednesday, January 30

PDUFA date for Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and Wyeth (NYSE: WYE)' Methylanaltrexone, an opioid receptor antagonists for treatment of opioid-induced constipation.
PDUFA date for Lev Pharmaceuticals, Inc. (OTC: LEVP)'s Cinryze for acute HAE.
Boeing Inc. (NYSE: BA) to report Q4 earnings; conference call at 10:30am.
Altria (NYSE: MO) to report Q4 earnings; conference call at 1:00pm.
Starbucks (NASDAQ: SBUX) to report Q1 earnings; conference call at 5:00pm.

Thursday, January 31

Friday, February 1

Exxon Mobil Corporation (NYSE: XOM) to report Q4 earnings; conference call at 11:00am.
PDUFA date for Axcan Pharma Inc. (NASDAQ: AXCA)'s for Ultrase/Ultrase MT (Pancrelipase) enzyme replacement therapy for treatment of chronic Pancreatitis and Pancreatic Deficiency related to Cystic Fibrosis.

Tags: axcan pharma, AxcanPharma, inthenews, lev pharmaceuticals, LevPharmaceuticals, progenics pharmaceuticals, ProgenicsPharmaceuticals, staffmark investment, StaffmarkInvestment, warner chillcott, WarnerChillcott, wyeth